A Phase III, Two-Part, Randomized, Double-Blind, Placebo Controlled, Multi-center Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK-0663/Etoricoxib in Patients with Rheumatoid Arthritis

Principal Investigator(s)

Charles H. Pritchard, M.D. (Sub-Investigator)

Mark Lopatin, M.D. (Sub-Investigator)

David J. Chesner, D.O. (Sub-Investigator)

Elana R. Eisner, M.D. (Sub-Investigator)

Marguerite L. McGarvey, M.D. (Sub-Investigator)

Dennis A. Jerdan, M.D. (Sub-Investigator)

C. Michael Franklin, M.D.

Clinical Trial Categories

• Arthritis

Contact

Sue Falbo at 215-657-9977